Novel use of a selectable fusion gene as an 'in-out' marker for studying genetic loss in mammalian cells

D.A. Trott, A.P. Cuthbert, C.M. Todd, M. Themis, R.F. Newbold

Research output: Contribution to journalArticle

Abstract

Recent demonstrations of loss of heterozygosity in a wide variety of human cancers suggest that large multilocus genetic deletions (presumably including tumor suppressor genes) constitute a major class of genetic alteration in human carcinogenesis. Here we show that a bifunctional fusion gene (Hytk), suitable for both positive and negative selection, is an effective marker for studying genetic loss in mammalian cells with minimal interference from point-mutational changes. Studies with a transgenic V79 cell line in which a single functional copy of Hytk was stably inserted into the genome in a retroviral vector showed that loss of the marker (and presumably flanking cellular genetic material) could be induced efficiently by ionizing radiation (γ-rays and fast neutrons) but only weakly by the powerful point-mutagen benzo[a]pyrene diol epoxide. In a first application of the system, we provide evidence that radiation-induced loss can occur through an indirect mechanism after a high-frequency event. Collectively, our results suggest that the Hytk marker should be a valuable tool for studying genome position effects on the tolerance of genetic loss in cultured human cells that represent different stages in clonal evolution and tumor progression.
Original languageEnglish
Pages (from-to)213-224
Number of pages12
JournalMolecular Carcinogenesis
Volume12
Issue number4
Publication statusPublished - 23 Apr 1995

Fingerprint

Gene Fusion
Genetic Markers
Genome
Clonal Evolution
Fast Neutrons
Loss of Heterozygosity
Benzo(a)pyrene
Epoxy Compounds
Gamma Rays
Mutagens
Ionizing Radiation
Tumor Suppressor Genes
Cultured Cells
Neoplasms
Carcinogenesis
Radiation
Cell Line
Genes

Keywords

  • 'In-out' selectable marker
  • Gene-deletion assay
  • Genome position effects
  • Loss of heterozygosity
  • animal cell
  • article
  • assay
  • carcinogenesis
  • V79 cell line
  • controlled study
  • gene deletion
  • heterozygosity
  • nonhuman
  • priority journal

Cite this

Novel use of a selectable fusion gene as an 'in-out' marker for studying genetic loss in mammalian cells. / Trott, D.A.; Cuthbert, A.P.; Todd, C.M.; Themis, M.; Newbold, R.F.

In: Molecular Carcinogenesis, Vol. 12, No. 4, 23.04.1995, p. 213-224.

Research output: Contribution to journalArticle

Trott, D.A. ; Cuthbert, A.P. ; Todd, C.M. ; Themis, M. ; Newbold, R.F. / Novel use of a selectable fusion gene as an 'in-out' marker for studying genetic loss in mammalian cells. In: Molecular Carcinogenesis. 1995 ; Vol. 12, No. 4. pp. 213-224.
@article{2f98ff08cd2f494bb08705bbb114db21,
title = "Novel use of a selectable fusion gene as an 'in-out' marker for studying genetic loss in mammalian cells",
abstract = "Recent demonstrations of loss of heterozygosity in a wide variety of human cancers suggest that large multilocus genetic deletions (presumably including tumor suppressor genes) constitute a major class of genetic alteration in human carcinogenesis. Here we show that a bifunctional fusion gene (Hytk), suitable for both positive and negative selection, is an effective marker for studying genetic loss in mammalian cells with minimal interference from point-mutational changes. Studies with a transgenic V79 cell line in which a single functional copy of Hytk was stably inserted into the genome in a retroviral vector showed that loss of the marker (and presumably flanking cellular genetic material) could be induced efficiently by ionizing radiation (γ-rays and fast neutrons) but only weakly by the powerful point-mutagen benzo[a]pyrene diol epoxide. In a first application of the system, we provide evidence that radiation-induced loss can occur through an indirect mechanism after a high-frequency event. Collectively, our results suggest that the Hytk marker should be a valuable tool for studying genome position effects on the tolerance of genetic loss in cultured human cells that represent different stages in clonal evolution and tumor progression.",
keywords = "'In-out' selectable marker, Gene-deletion assay, Genome position effects, Loss of heterozygosity, animal cell, article, assay, carcinogenesis, V79 cell line, controlled study, gene deletion, heterozygosity, nonhuman, priority journal",
author = "D.A. Trott and A.P. Cuthbert and C.M. Todd and M. Themis and R.F. Newbold",
year = "1995",
month = "4",
day = "23",
language = "English",
volume = "12",
pages = "213--224",
journal = "Molecular Carcinogenesis",
issn = "0899-1987",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Novel use of a selectable fusion gene as an 'in-out' marker for studying genetic loss in mammalian cells

AU - Trott, D.A.

AU - Cuthbert, A.P.

AU - Todd, C.M.

AU - Themis, M.

AU - Newbold, R.F.

PY - 1995/4/23

Y1 - 1995/4/23

N2 - Recent demonstrations of loss of heterozygosity in a wide variety of human cancers suggest that large multilocus genetic deletions (presumably including tumor suppressor genes) constitute a major class of genetic alteration in human carcinogenesis. Here we show that a bifunctional fusion gene (Hytk), suitable for both positive and negative selection, is an effective marker for studying genetic loss in mammalian cells with minimal interference from point-mutational changes. Studies with a transgenic V79 cell line in which a single functional copy of Hytk was stably inserted into the genome in a retroviral vector showed that loss of the marker (and presumably flanking cellular genetic material) could be induced efficiently by ionizing radiation (γ-rays and fast neutrons) but only weakly by the powerful point-mutagen benzo[a]pyrene diol epoxide. In a first application of the system, we provide evidence that radiation-induced loss can occur through an indirect mechanism after a high-frequency event. Collectively, our results suggest that the Hytk marker should be a valuable tool for studying genome position effects on the tolerance of genetic loss in cultured human cells that represent different stages in clonal evolution and tumor progression.

AB - Recent demonstrations of loss of heterozygosity in a wide variety of human cancers suggest that large multilocus genetic deletions (presumably including tumor suppressor genes) constitute a major class of genetic alteration in human carcinogenesis. Here we show that a bifunctional fusion gene (Hytk), suitable for both positive and negative selection, is an effective marker for studying genetic loss in mammalian cells with minimal interference from point-mutational changes. Studies with a transgenic V79 cell line in which a single functional copy of Hytk was stably inserted into the genome in a retroviral vector showed that loss of the marker (and presumably flanking cellular genetic material) could be induced efficiently by ionizing radiation (γ-rays and fast neutrons) but only weakly by the powerful point-mutagen benzo[a]pyrene diol epoxide. In a first application of the system, we provide evidence that radiation-induced loss can occur through an indirect mechanism after a high-frequency event. Collectively, our results suggest that the Hytk marker should be a valuable tool for studying genome position effects on the tolerance of genetic loss in cultured human cells that represent different stages in clonal evolution and tumor progression.

KW - 'In-out' selectable marker

KW - Gene-deletion assay

KW - Genome position effects

KW - Loss of heterozygosity

KW - animal cell

KW - article

KW - assay

KW - carcinogenesis

KW - V79 cell line

KW - controlled study

KW - gene deletion

KW - heterozygosity

KW - nonhuman

KW - priority journal

M3 - Article

VL - 12

SP - 213

EP - 224

JO - Molecular Carcinogenesis

JF - Molecular Carcinogenesis

SN - 0899-1987

IS - 4

ER -